Protagenic Therapeutics, Inc.\new Derivative Liability, Current
Protagenic Therapeutics, Inc.\new (PTIX) had Derivative Liability, Current of $544.35 thousand as of 2025-12-31, per its 10-Q filed 2026-03-09.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2026-08-14
- 2025-12-31: Derivative Liability, Current $544.35K.
- 2025-09-30: Derivative Liability, Current $3.66M.
- 2025-06-30: Derivative Liability, Current $3.86M.
- 2025-03-31: Derivative Liability, Current $1.38M.
| Period end | Derivative Liability, Current |
|---|---|
| 2025-12-31 | $544.35K 10-Q · filed 2026-03-09 |
| 2025-09-30 | $3.66M 10-Q · filed 2025-11-26 |
| 2025-06-30 | $3.86M 10-QT · filed 2025-09-10 |
| 2025-03-31 | $1.38M 10-K · filed 2026-08-14 |
| 2020-12-31 | $83.67K 10-K · filed 2022-04-07 |
| 2020-09-30 | $190.31K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $295.03K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $271.47K 10-Q · filed 2020-06-18 |
| 2019-12-31 | $332.22K 10-K · filed 2021-03-25 |
| 2019-09-30 | $334.97K 10-Q · filed 2019-11-14 |
| 2019-06-30 | $400.18K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $626.68K 10-Q · filed 2019-05-16 |
| 2018-12-31 | $676.08K 10-K · filed 2020-04-29 |
| 2018-09-30 | $408.09K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $407.62K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $419.68K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $425.84K 10-K · filed 2019-03-29 |
| 2017-09-30 | $435.36K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $504.33K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $516.99K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $516.87K 10-K · filed 2018-04-02 |
| 2016-09-30 | $516.76K 10-Q · filed 2016-11-17 |
| 2016-06-30 | $515.82K 10-Q · filed 2016-08-15 |
| 2016-03-31 | $488.93K 10-Q · filed 2016-07-25 |
| 2011-09-30 | $1.88M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $3.26M 10-Q/A · filed 2011-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |